These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 27785023)
1. Synergistic effects of A-B-C-type amphiphilic copolymer on reversal of drug resistance in MCF-7/ADR breast carcinoma. Zhang L; Lu J; Qiu L Int J Nanomedicine; 2016; 11():5205-5220. PubMed ID: 27785023 [TBL] [Abstract][Full Text] [Related]
2. Amphiphilic Copolymeric Micelles for Doxorubicin and Curcumin Co-Delivery to Reverse Multidrug Resistance in Breast Cancer. Lv L; Qiu K; Yu X; Chen C; Qin F; Shi Y; Ou J; Zhang T; Zhu H; Wu J; Liu C; Li G J Biomed Nanotechnol; 2016 May; 12(5):973-85. PubMed ID: 27305819 [TBL] [Abstract][Full Text] [Related]
3. Enhanced effect of pH-sensitive mixed copolymer micelles for overcoming multidrug resistance of doxorubicin. Qiu L; Qiao M; Chen Q; Tian C; Long M; Wang M; Li Z; Hu W; Li G; Cheng L; Cheng L; Hu H; Zhao X; Chen D Biomaterials; 2014 Dec; 35(37):9877-9887. PubMed ID: 25201738 [TBL] [Abstract][Full Text] [Related]
4. Overcoming multidrug resistance by intracellular drug release and inhibiting p-glycoprotein efflux in breast cancer. Mao J; Qiu L; Ge L; Zhou J; Ji Q; Yang Y; Long M; Wang D; Teng L; Chen J Biomed Pharmacother; 2021 Feb; 134():111108. PubMed ID: 33341670 [TBL] [Abstract][Full Text] [Related]
5. Reversing of multidrug resistance breast cancer by co-delivery of P-gp siRNA and doxorubicin via folic acid-modified core-shell nanomicelles. Wu Y; Zhang Y; Zhang W; Sun C; Wu J; Tang J Colloids Surf B Biointerfaces; 2016 Feb; 138():60-9. PubMed ID: 26655793 [TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism study of chemosensitization of doxorubicin-resistant human myelogenous leukemia cells induced by a composite polymer micelle. Han M; Diao YY; Jiang HL; Ying XY; Chen DW; Liang WQ; Gao JQ Int J Pharm; 2011 Nov; 420(2):404-11. PubMed ID: 21945184 [TBL] [Abstract][Full Text] [Related]
7. Surfactin-based nanoparticles loaded with doxorubicin to overcome multidrug resistance in cancers. Huang W; Lang Y; Hakeem A; Lei Y; Gan L; Yang X Int J Nanomedicine; 2018; 13():1723-1736. PubMed ID: 29606866 [TBL] [Abstract][Full Text] [Related]
8. Micelles of d-α-Tocopheryl Polyethylene Glycol 2000 Succinate (TPGS 2K) for Doxorubicin Delivery with Reversal of Multidrug Resistance. Hao T; Chen D; Liu K; Qi Y; Tian Y; Sun P; Liu Y; Li Z ACS Appl Mater Interfaces; 2015 Aug; 7(32):18064-75. PubMed ID: 26214761 [TBL] [Abstract][Full Text] [Related]
9. 7-O-geranylquercetin contributes to reverse P-gp-mediated adriamycin resistance in breast cancer. Zhang E; Liu J; Shi L; Guo X; Liang Z; Zuo J; Xu H; Wang H; Shu X; Huang S; Zhang S; Kang X; Zhen Y Life Sci; 2019 Dec; 238():116938. PubMed ID: 31593704 [TBL] [Abstract][Full Text] [Related]
10. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells. Wang J; Qu H; Jin L; Zeng W; Qin L; Zhang F; Wei X; Lu W; Zhang C; Liang W J Pharm Sci; 2011 Jun; 100(6):2267-77. PubMed ID: 21246559 [TBL] [Abstract][Full Text] [Related]
11. Reversal of P-glycoprotein-mediated multidrug resistance is induced by saikosaponin D in breast cancer MCF-7/adriamycin cells. Li C; Guan X; Xue H; Wang P; Wang M; Gai X Pathol Res Pract; 2017 Jul; 213(7):848-853. PubMed ID: 28554760 [TBL] [Abstract][Full Text] [Related]
12. Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance. Wang J; Sun J; Chen Q; Gao Y; Li L; Li H; Leng D; Wang Y; Sun Y; Jing Y; Wang S; He Z Biomaterials; 2012 Oct; 33(28):6877-88. PubMed ID: 22770799 [TBL] [Abstract][Full Text] [Related]
13. Reversing multidrug resistance by intracellular delivery of Pluronic® P85 unimers. Hong W; Chen D; Zhang X; Zeng J; Hu H; Zhao X; Qiao M Biomaterials; 2013 Dec; 34(37):9602-14. PubMed ID: 24021757 [TBL] [Abstract][Full Text] [Related]
14. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles. Yu P; Yu H; Guo C; Cui Z; Chen X; Yin Q; Zhang P; Yang X; Cui H; Li Y Acta Biomater; 2015 Mar; 14():115-24. PubMed ID: 25498306 [TBL] [Abstract][Full Text] [Related]
15. Active-targeting and acid-sensitive pluronic prodrug micelles for efficiently overcoming MDR in breast cancer. Xu C; Xu J; Zheng Y; Fang Q; Lv X; Wang X; Tang R J Mater Chem B; 2020 Apr; 8(13):2726-2737. PubMed ID: 32154530 [TBL] [Abstract][Full Text] [Related]
16. Doxorubicin Encapsulated in TPGS-Modified 2D-Nanodisks Overcomes Multidrug Resistance. Jiang T; Zhang C; Sun W; Cao X; Choi G; Choy JH; Shi X; Guo R Chemistry; 2020 Feb; 26(11):2470-2477. PubMed ID: 31912555 [TBL] [Abstract][Full Text] [Related]
17. Novel polymer micelle mediated co-delivery of doxorubicin and P-glycoprotein siRNA for reversal of multidrug resistance and synergistic tumor therapy. Zhang CG; Zhu WJ; Liu Y; Yuan ZQ; Yang SD; Chen WL; Li JZ; Zhou XF; Liu C; Zhang XN Sci Rep; 2016 Mar; 6():23859. PubMed ID: 27030638 [TBL] [Abstract][Full Text] [Related]
18. Reversing P-Glycoprotein-Associated Multidrug Resistance of Breast Cancer by Targeted Acid-Cleavable Polysaccharide Nanoparticles with Lapatinib Sensitization. Sui J; He M; Yang Y; Ma M; Guo Z; Zhao M; Liang J; Sun Y; Fan Y; Zhang X ACS Appl Mater Interfaces; 2020 Nov; 12(46):51198-51211. PubMed ID: 33147005 [TBL] [Abstract][Full Text] [Related]